Hypertension in chronic obstructive pulmonary disease (COPD): A review of current practice
R. Cooper (Telford, United Kingdom), W. Po Fung (Telford, United Kingdom), A. Perry (Telford, United Kingdom), J. Greenway (Telford, United Kingdom), H. Moudgil (Telford, United Kingdom), K. Srinivasan (Telford, United Kingdom), A. Makan (Telford, United Kingdom), E. Crawford (Telford, United Kingdom), N. Ahmad (Telford, United Kingdom)
Source: Virtual Congress 2020 – Clinical and basic pharmacology for COPD
Session: Clinical and basic pharmacology for COPD
Session type: E-poster session
Number: 184
Disease area: Airway diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
R. Cooper (Telford, United Kingdom), W. Po Fung (Telford, United Kingdom), A. Perry (Telford, United Kingdom), J. Greenway (Telford, United Kingdom), H. Moudgil (Telford, United Kingdom), K. Srinivasan (Telford, United Kingdom), A. Makan (Telford, United Kingdom), E. Crawford (Telford, United Kingdom), N. Ahmad (Telford, United Kingdom). Hypertension in chronic obstructive pulmonary disease (COPD): A review of current practice. 184
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: